Busetto L, Bettini S, Makaronidis J, Roberts CA, Halford JCG, Batterham RL
Effective management of gastrointestinal side effects can significantly improve treatment tolerance and adherence to Ozempic therapy
Red flags include: Peptides sold without physician prescription or clinical oversight No third-party COA available or offered Unusually low pricing relative to pharmaceutical-grade standards Claims of efficacy that exceed what any peer-reviewed evidence supports "Research use only" labelling combined with implicit human use marketing Physician-supervised protocols through a licensed compounding pharmacy are the only appropriate framework for clinical use of CJC-1295 and ipamorelin
Reconstituted vials must be stored in amber glass or wrapped in aluminum foil to block light transmission
J Endocrinol (2010) 205(3):20110
Yew Tan C, Virtue S, Murfitt S, Roberts LD, Phua YH, Dale M, et al